Investigational pharmacology for low back pain

References

• FreynhagenRBaronRThe evaluation of neuropathic components in low back painCurr Pain Headache Rep200913318519019457278
   PubMed Web of Science ®Google Scholar
• DeyoRMirzaSTurnerJMartinBOvertreating chronic back pain: time to back off?J Am Board Fam Med2009221626819124635
   PubMed Web of Science ®Google Scholar
• DagenaisSA systematic review of low back pain cost of illness studies in the united states and internationallySpine J20088182018164449
   PubMed Web of Science ®Google Scholar
• BorensteinDDoes osteoarthritis of the lumbar spine cause chronic low back pain?Curr Rheumatol Rep200461141914713398
   PubMedGoogle Scholar
• AltmanRPractical considerations for the pharmacologic management of osteoarthritisAm J Manag Care2009158236243
   Google Scholar
• WindsorRSullivanKLumbosacral disc injuries. eMedicine website. eMedicine, Specialties/Sports Medicine/Spine Available at http://emedicine.medscape.com/. Accessed on April 9, 2010.
   Google Scholar
• MalangaGChimesGLumbosacral facet syndrome. eMedicine website eMedicine, Specialties/Sports Medicine/Spine, Available on http://emedicine.medscape.com. Accessed on April 12, 2010.
   Google Scholar
• AshtonIKAshtonBAGibsonSJPolakJMJaffrayDCMorphological basis for back pain: the demonstration of nerve fibers and neuropeptides in the lumbar facet joint capsule but not in ligamentum flavumJ Orthop Res200510172781530799
   PubMed Web of Science ®Google Scholar
• KalichmanLHunterDLumbar facet joint osteoarthritis: a reviewSemin Arthritis Rheum2007372698017379279
   PubMed Web of Science ®Google Scholar
• PollintinePPrzybylaASDolanPAdamsMANeural arch load-bearing in old and degenerated spinesJ Biomech200737219720414706322
   PubMed Web of Science ®Google Scholar
• SowaGAgarwalSCyclic tensile stress exerts a protective effect on intervertebral disc cellsAm J Phys Med Rehabil200887753754418209665
   PubMed Web of Science ®Google Scholar
• MappPIWalshDABowyerJMaciewiczRAEffects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritisOsteoarthritis Cartilage201018459360020067755
   PubMed Web of Science ®Google Scholar
• BonnetCSWalshDAOsteoarthritis, angiogenesis and inflammationRheumatology200544171615292527
   PubMed Web of Science ®Google Scholar
• ReadSDrayAOsteoarthritic pain: a review of current, theoretical and emerging therapeuticsExpert Opin Investig Drugs2008175619640
   PubMed Web of Science ®Google Scholar
• AtturMSamuelsJKrasnokutskySAbramsonSTargeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?Best Pract Res Clin Rheumatol2010241717920129201
   PubMed Web of Science ®Google Scholar
• FunkCDProstaglandins and leukotrienes: advances in eicosanoid biologyScience200129454481871187511729303
   PubMed Web of Science ®Google Scholar
• Martel-PelletierJLajeunesseDReboulPPelletierJ-PTherapeutic role of dual inhibitors of 5-lox and cox, selective and non-selective non-steroidal anti-inflammatory drugsAnn Rheum Dis200362650150912759283
   PubMed Web of Science ®Google Scholar
• DingCCicuttiniFLicofelone (Merckle)IDrugs20036880280812917777
   PubMed Web of Science ®Google Scholar
• de GaetanoGDonatiMCerlettiCPrevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined cox-1, cox-2 and 5-lox inhibitorsTrends Pharmacol Sci200324524525212767724
   PubMed Web of Science ®Google Scholar
• KulkarniSKSinghVPLicofelone-a novel analgesic and anti-inflammatory agentCurr Top Med Chem20077325126317305568
   PubMed Web of Science ®Google Scholar
• Alvaro-GraciaJMLicofelone – clinical update on a novel lox/cox inhibitor for the treatment of osteoarthritisRheumatology2004431i23i25
   Google Scholar
• KulkarniSKSinghVPLicofelone: the answer to unmet needs in osteoarthritis therapy?Curr Rheum Rep20081014348
   PubMedGoogle Scholar
• BiasPBuchnerAKlesserBLauferSThe gastrointestinal tolerability of the lox/cox inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trialAm J Gastroenterol20049961161815089890
   PubMed Web of Science ®Google Scholar
• Third pivotal phase 3 study for nicox’ naproxcinod shows positive efficacy, safety and blood pressure results Available from: http://www.medicalnewstoday.com. Accessed on Mar 2, 2010.
   Google Scholar
• BannwarthBBérenbaumFLumiracoxib in the management of osteoarthritis and acute painExpert Opin Pharmacother20078101551156417661736
   PubMed Web of Science ®Google Scholar
• RordorfCChoiLMarshallPMangoldJClinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitorClin Pharmacokinet200544121247126616372823
   PubMed Web of Science ®Google Scholar
• TonerBRayTNovartis adds companion dx to lumiracoxib resubmission in Europe Pharmacogenomics Reporter. Available from: http://www.genomeweb.com. Accessed on Mar 15, 2010.
   Google Scholar
• MartinBDeyoRMirzaSTurnerJExpenditures and health status among adults with back and neck problemsJAMA2008299665666418270354
   PubMed Web of Science ®Google Scholar
• CahillCMorinvilleALeeM-CProlonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociceptionJ Neurosci200121197598760711567050
   PubMed Web of Science ®Google Scholar
• Delta opioid receptor agonist program Available from: http://www.adolor.com. Accessed on May 20, 2010.
   Google Scholar
• MenéndezLLastraAMeanaAHidalgoABaamondeAAnalgesic effects of loperamide in bone cancer pain in micePharmacol Biochem Behav200581111412115894068
   PubMed Web of Science ®Google Scholar
• WhitesideGTBouletJMWalkerKThe role of central and peripheral μ opioid receptors in inflammatory pain and edema: a study using morphine and dipoa ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid)J Pharmacol Exp Ther200531451234124015937151
   PubMed Web of Science ®Google Scholar
• SilvermanSLAzriaMThe analgesic role of calcitonin following osteoporotic fractureOsteoporos Int2002131185886712415432
   PubMed Web of Science ®Google Scholar
• LyritisGPTsakalakosNMagiasisBKarachaliosTAnalgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical studyCalcif Tissue Int19914963693721818759
   PubMed Web of Science ®Google Scholar
• LyritisGPPaspatiIKarachaliosTIoakimidisDPain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. a double blind, placebo-controlled clinical studyActa Orthop Scand Suppl19972751121149385283
   PubMedGoogle Scholar
• ManicourtD-HAzriaMMindeholmLThonarEOral salmon calcitonin reduces lequesne’s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritisArthritis Rheum200654103205321117009253
   PubMed Web of Science ®Google Scholar
• JankovicJSchwartzKBotulinum toxin injections for cervical dystoniaNeurology1990402772802300249
   PubMed Web of Science ®Google Scholar
• FilippiJErricoKSantarelliRBagoliniBBotulinum a toxin effects on rat jaw muscle spindlesActa Oto-laryngol19931133400404
   PubMed Web of Science ®Google Scholar
• JabbariBTreatment of chronic low back pain with botulinum neurotoxinsCurr Pain Headache Rep200711535235817894925
   PubMedGoogle Scholar
• FosterLClappLEricksonMJabbariBBotulinum toxin a and chronic low back painNeurology2001561290129311376175
   PubMed Web of Science ®Google Scholar
• JabbariBNeyJSichaniATreatment of refractory, chronic low back pain with botulinum toxin a: a prospective open label study with 14 months follow upPain Med2006726026416712627
   PubMed Web of Science ®Google Scholar
• AokiKRTreatment of chronic low back pain with botulinum neurotoxinsHeadache J Head Face Pain2003431915
   Google Scholar
• WoolfCSalterMNeuronal plasticity: increasing the gain in painScience200028854721765176810846153
   PubMed Web of Science ®Google Scholar
• MerskeyHBogdukNClassification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms2nd edSeattleIASP Press1994
   Google Scholar
• PappagalloMThe Neurological Basis of Pain1st edNew YorkMcGraw-Hill2004
   Google Scholar
• RicheimerSUnderstanding neuropathic pain. Spine Universe website Available from: http://www.spineuniverse.com/conditions/understanding-neuropathic-pain. Accessed on Jun 2, 2010.
   Google Scholar
• DrayANeuropathic pain: emerging treatmentsBr J Anaesth20081011485818511441
   PubMed Web of Science ®Google Scholar
• DevorMSodium channels and mechanisms of neuropathic painJ Pain200571S3S1216426998
   PubMed Web of Science ®Google Scholar
• MathurMZiconotide: a new pharmacological class of drugs for the management of painSemin Anesth2000196775
   Google Scholar
• OliveraBGrayWRZeikusRMcIntoshJMPeptide neurotoxins from fish hunting cone snailsScience19852304732133813434071055
   PubMed Web of Science ®Google Scholar
• WallaceMCharapataSFisherRIntrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trialNeuromodulation2006927586
   PubMed Web of Science ®Google Scholar
• SmithHDeerTSafety and efficacy of intrathecal ziconotide in the management of severe chronic painTher Clin Risk Manag2009552153419707262
   PubMedGoogle Scholar
• MaoJN-type calcium channel blocker for pain treatmentPain Med201011226227320002322
   PubMed Web of Science ®Google Scholar
• KolosovAGoodchildCCookeICnsb004 (leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic painPain Med200911226227320002322
   PubMed Web of Science ®Google Scholar
• RamseyJDellingMClaphamDAn introduction to TRP channelsAnnu Rev Physiol20066861964716460286
   PubMed Web of Science ®Google Scholar
• SzallasiABlumbergP(capsaicin) receptors and mechanismsPharmacol Rev199951215921210353985
   PubMed Web of Science ®Google Scholar
• BackonjaMMMalanPVanhoveGTobiasJNgx-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extensionPain Med201011460060820113411
   PubMed Web of Science ®Google Scholar
• Garcia-MartinezCHumetMPlanells-CasasRAttenuation of thermal nociception and hyperalgesia by VR1 blockersProc Natl Acad Sci U S A20029942374237911854530
   PubMed Web of Science ®Google Scholar
• AgarwalNPacherPTegederIAmayaFCannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptorsNat Neurosci20071087087917558404
   PubMed Web of Science ®Google Scholar
• GutierrezTFarthingJNZvonokAMMakriyannisAActivation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysisBr J Pharmacol2007150215316317160008
   PubMed Web of Science ®Google Scholar
• LaBudaCKoblishMLittlePCannabinoid CB2 receptor agonist activity in the hindpaw incisionmodel of postoperative painEur J Pharmacol2005527117217416316653
   PubMed Web of Science ®Google Scholar
• TurcotteTLe DorzeJNEsfahaniAMFrostAExamining the roles of cannabinoids in pain and other therapeutic indications: a reviewExpert Opin Pharmacother2010111173120001426
   PubMed Web of Science ®Google Scholar
• WoodfordeJMDwyerBMcEwenBWDeWildeFWBleaselKTreatment of post-herpetic neuralgiaMed J Aust196528698725852886
   PubMedGoogle Scholar
• MaxMBCulnaneMSchaferSCGracelyRHWaltherDJAmitryptyline relieves diabetic neuropathy pain in patients with normal or depressed moodNeurology1987375895962436092
   PubMed Web of Science ®Google Scholar
• SalernoSMBrowningRJacksonJLThe Effect of antidepressant treatment on chronic back pain: a meta-analysisArch Intern Med2002162192411784215
   PubMedGoogle Scholar
• ChanHNFamJNgBYUse of antidepressants in the treatment of chronic painAnn Acad Med Singapore20093897497919956820
   PubMed Web of Science ®Google Scholar
• VrankenJMechanisms and treatment of neuropathic painCent Nerv Syst Agents Med Chem20099717820021340
   PubMedGoogle Scholar
• YalcinITessierLHPetit-DemouliereNDoridotSHeinLBeta 2-adrenoreceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic painNeurobiol Dis20093338639419084064
   PubMed Web of Science ®Google Scholar
• YalcinIChoucair-JaafarNBenbouzidMTessierLHMullerABeta (2)-adrenoreceptors are critical for antidepressant treatment of neuropathic painAnn Neurol20096521822519259968
   PubMed Web of Science ®Google Scholar
• BarrotMYalcinIChoucair-JaafarNBenbouzidMFreund-MercerMJFrom antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic painRecent Pat CNS Drug Discov2009418218919538157
   PubMedGoogle Scholar
• Choucair-JaafarNYalcinIRodeauJWaltispergerEFreund-MercierMB2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatmentBr J Pharmacol20091581683169419912227
   PubMed Web of Science ®Google Scholar
• YalcinITessierLHPetit-DemouliereNWaltispergerEHeinLChronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic painExp Neurol201022111512119840789
   PubMed Web of Science ®Google Scholar